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Binding of Bullous Pemphigoid Antibodies to Basal Cells 
TAKEJI NISHIKAWA, M.D. , SEIICHI KURIHARA, M.D., TAKASHI HARADA, M.D. , AND HITOSHI HATANO, M.D. 
Department of Dermatology, K eio University School of M edicine, Tohyo, Japan 
Eight out of 12 serum samples from patients with 
bullous pemphigoid having basement membrane zone 
antibodies gave positive binding not only to the base-
Jl).ent membrane zone but also to the basal cell membrane 
and/or cytoplasm as observed by complement immuno-
fluorescence. R eaction of fluorescein labeled pemphigus 
vulgaris y-globulins, binding mainly to the lower inter-
cellular spaces of the epidermis, was greatly reduced by 
tbe prior incubation of high-titered bullous pemphigoid 
sera having the reactivity to the basal cells, while that 
of fluorescein labeled pemphigus foliaceus y-globulins 
binding mainly to the upper and middle intercellular 
spaces, was not influenced by the prior application of 
these bullous pemphigoid sera. These results indicate 
that bullous pe mphigoid antibodies are heterogenous 
and can be classified into 2 types and that some cross 
reaction is present between pemphigus antibodies and 
bullous pemphigoid antibodies having the r eactivity to 
the basal cells. 
Bullous pemphigoid (BP) is a chronic bullous derm atosis 
char acterized by the presence of au toan t ibodies against base-
ment m embra n e zon e (BMZ) of the s kin (1]. Using complemen t 
immunofluorescence (IF) , we confirmed th e comple m ent-fixing 
capacity o f BP antibodies and found by chance t hat som e BP 
sera react not only with t h e BMZ bu t a lso wi t h th e cell 
membrane a nd /or cytoplasm of the proliferating basalioid cells 
of se borrhe ic keratosis (unpublish ed data). 
In this study, we report that t his posit ive binding of PB 
a ntibodies to t h e basal cells can be seen even in t h e BCM a nd/ 
or BCC of normal huma n e pidermis. According to their staining 
pattern, BP a nti bodies can b e classified into 2 types, one with 
BMZ a nd basal cell binding a nd the oth er wi t h BMZ binding 
o nly. In a ddition, the serological cross reactivity between BP 
a nd pemphigus a nt ibodies will be r epor ted. 
MATERIALS AND METHODS 
Serum 
Twelve serum samples from patients with BP were included. Each 
serum hav ing BMZ antibod ies in t iters ranging from 1:160 to 1:10,240 
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Abbreviations: 
BCC: basal cell cytoplasm 
BCM: basal cell membrane 
BMZ: basement membrane zone 
BP: bullous pemphigoid 
FITC: flu orescein isothiocyanate 
ICS: in tercellular space 
IF: immunofluorescence 
PBS: phosphate buffered saline 
conta ined complement-fixing BMZ antibodies in t iters from 1:20 to 1: 
640. Each serum was tested at 1:20 dilu tion after inactivation at 56°C 
for 30 min. Immunoglobulin classes of BMZ antibodies were shown to 
be IgG in each case with indirect IF with FITC labeled anti-human 
IgG, lgA, lgM respectively. Furthermore, the identity of t he antibodies 
was confirmed by absorption of the sera with anti-human l gG. 
S ubstrates 
Normal human skin, obtained by skin biopsy was immediately frozen 
in d.ry ice-acetone, embedded in a Matrix (Lipshow, Detroit, U.S.A.), 
cut in to 4-6 J.lm sections in a cryostat and were used unfixed. 
Labeled Antisera 
Commercially obtained FITC labeled antisera (Hyland D ivision, 
Travenol Lab., U.S.A.) were used for indirect IF and complement IF. 
The molar flu orescein protein ratio, specific antibody concentrations of 
the conjugates and dilutions employed were as fo llows: for IgG: 3.0, 2.0 
mg/ml, 1:40; for IgM: 3.3, 1.9 mg/ ml, 1:20; for IgA: 3.0, 1.2 mg/ ml, 1 :20; 
and for C3: 2.5, 2.5 mg/ ml, 1:32. Specificity was confirmed by immu-
noelectrophoresis. 
Im.munofluorescen.ce 
Indirect IF was performed in t he standard manner to test the sera of 
patients with BP for t he presence of BMZ antibodies. Compl~ment IF 
was assessed by the method described by Jordon eta! [2,3]. Briefly, 3 
dTops of the inactivated BP serum were applied to the human skin 
sections and the same amo un t of fresh norma l human serum dilu ted 1: 
2.5 with phosphate buffered saline (PB ) with Mg2+ and Ca2+ as a 
source of complement were overla id on the sections. The sections were 
then incubated in a moist chamber at 37°C fo r 30 min. Following a 
PBS rinse, the ·ections were treated with the FITC rabbit antiserum 
against human C3 (Hyland) at 37°C for 30 min. T he slides were rinsed 
aga in with the same buffer and mounted with covers! ips in 50% glycerol-
PBS. The specimens were examined with a T iyoda flu orescence micro-
scope equipped with Osram HBO mercury vapor lamp and dark fie ld 
condensor. The specificity of complement IF was confu·med as de-
scribed previously [31-
Prepara.tion. of FJTC Labeled Pemphigus Antibodies 
Conju gation of y-globulins from 2 cases of patients with pemphigus 
(TY & MH) with FITC was perfo rmed through the courtesy of Dr. S. 
Kano of the Centra l Chemical Laboratory o r Keio Univers ity Hospita l 
accordmg to th e method of Wood, Thompson and Goldste in [4l To 
take mto cons1derat10n the re lative concentration of antibodies within 
sera and conjugates, a system of uni ts was used. One uni t corresponds 
to the highest dilution giving posit ive IF. 
Bloching lnwwnofluorescence 
T he la beled pemph igus antibod ies were used in block ing experiments 
to cletermme whether BP antibodies having ICS binding cross react 
with pemphigus antibodies. Skin sections were incubated with BP 
serum for 30 min at 37°C. After a PBS rinse for 15 min, they were 
stawed wtth the FITC labeled pemphigus antibodies. 
RESULTS 
Binding of BP Sera with BMZ and BCM and/or BCC of 
Basal Cells 
Of the 12 serum samples, 8 gave positive IF at both BMZ 
a nd B CM and / or BCC as observed by complem e nt IF (Figure 
1) , though th ese sera showed n o clear binding to t h e basal cells 
by t h e ordinary IgG indirect IF. Each BP an t ibody was of IgG 
type . This p ositive fluorescence was not demonstrated after the 
serum was incubated with excess a m oun t of r a bbit anti-human 
IgG. The positive reaction to t h e basal cells a nd BMZ was not 
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Complement immunoflu orescence of a bullous pemphigo id serum 
(TH ) giving basement membrane zone (BM Z) and basal ce ll staining. 
Posit ive flu orescence at B MZ, basa l ce ll membrane and so me basa l cell 
cytoplasm (reduced from x 400) . 
TABL I<: I. Correlation of intercellular binding by bullous pemphigoid 
antibodies with total lgG and complement-fi xing lgG antibody tiler 
Basement. membrane zone Site o f positive sta in· 
(B MZ) antibody t. iter 
No. Patient 
Anti-lgG" An ti-C3" 
1 c.s. 1280 80 
2 H.l. 1280 20 
3 U.N . 640 80 
4 K.T. 5 120 80 
5 S .A. 160 20 
6 K.T a . 640 40 
7 H .N. 320 20 
8 M.S. 320 20 
9 T.H. 640 160 
10 T .S. JGO 20 
11 N .l. 10240 640 
12 A.Sh. 320 40 
"Ordinary IgG indirect immunofluorescence (IF). 
"Complement IF. 
BMZ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
·· Complement IF was performed at 1:20 serum dilu t ion. 
ing·· 
Basal 
cell" 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
" P ositive flu orescence at t he basa l cell membrane and/or basa l ce ll 
cytoplasm . 
P. 
T ABL E II. Characteris t ic~; of fluorescein i::;o thiocyanale labeled 
pemphigus antibodies 
Source Molar Ti ter PosiLive Dilution F/ P sta ining used 
foliaceus (MH) 3.4 1: 40 Upper & middl e 2 uni ts" 
ICS" 
P. vulgm·is (TY) 2.5 1:40 Lower ICS 2 units 
" ICS: in te rcellular spaces. 
"Uni t: one uni t is equa l to highest dilutions giving positive staining. 
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demonstrated after the heat inactivation of the added h·esh 
human serum. Blocking test using ant i-human C3 also revealed 
the specificity of the C3 staining. This established that positive 
basal cell binding was caused by the reaction of C3 to th e IgG 
class BMZ antibodies bound to the B CM and/or B CC. No clear 
correlation of basal cell binding by BP ant ibodies with the 
indirect IF antibody titer was observed as shown in T a ble I. 
Binding of FITC L abeled Pemphig us Antibodies and the 
Serological Cross R eaction with BP Antibodies 
The characteristics of FITC la beled pemphigus antibodies 
are shown in T a ble II. FITC la beled pemphigus foliaceus anti-
bodies h·om case MH reacted mainly with upper and middle 
ICS as described by Bystryn, Abel, and DeFeo [5], while 
conjugated pemphigus vulgaris ant ibodies from case T Y ~;eacted 
with lower ICS only as described by Wood and Beutner [6]. 
Sera from pa tients with BP were assessed for theil· capa bili ty 
to block subsequent FITC labeled pemphigus antibodies. As 
shown in T able Ill, BP sera wi th basal cell binding (TH) 
blocked reaction of the subsequent application of FITC la beled 
pemphigus antibodies at higher concentration. This effect was 
more remarkable in the case of FITC la beled pemphigus vul-
garis (TY) than pemphigus foliaceus (MH) ant ibodies. H ow-
ever, BP sera wi thout basal cell binding (CS and MS) gave no 
effect on the subsequent staining of FITC la beled pemphigus 
antibodies from both forms (MH and TY) even a t higher 
concentration. 
DISCUSSION 
Basement membrane zone of the skin is ultrastructmallY 
divided into 4 components: (1) basal cell plasma membrane 
with its special attachment devices, hemidesmosomes, (2) the 
lamina Iucida (or intermembranous space), (3) the basal lamina 
(basal membrane, basement membrane, lamina densa, adepi-
dermal membrane) and (4) t he sub-basal lamina fibrous ele-
ments including anchoring fibrils, dermal microfibril bundles 
and collagen fibers [7]. By immunoelectron microscopy BP 
antibodies are found to react with antigen located in the lamina 
Iucida [8,9]. Furthermore, t his antigen has been isolated h·om 
human skin [10] and the urine of a patient wi th BP [11]. 
Besides BP antigen, other components of the BMZ such as the 
basal lamina (coll agen typ e IV) have been studied by immu-
nological techniques [12,13]. 
Our present work clearly demonstrates that the majority of 
BP antibodies are reactive not only with BMZ bu t also with 
BCM and/ or BCC using complement IF in which the staina-
bility is usua lly amplified by the binding of C3 to each antigen-
antibody complex. This observation verifies the possibility that 
antibodies can be present yet undemonstrable by the ordinary 
IgG indirect IF [14]. A similar phenomenon has recently been 
demonstrated in the case of au toimmune vitiligo in which 
antibodies against melanin producing cells could be detected 
with complement IF bu t not with t he ordinary l gG indirect IF 
T ABLE III. Blocl1ing of the binding of flu orescein. isoth iocyanate (FTTC) labeled bullous pemphigoid (B P) antibodies lo the basal cell of the 
ep idermis by pemp higus antibodies 
H.I. 
T .H . 
C.S. 
M.S . 
NHs·· 
BP-Ab tite r 
1280 
640 
1280 
320 
Positive staini ng 
BMZ& B CM 
BMZ & BCM 
BM Z 
BM Z 
FITC- M.J-1." 
Uni t. used 
Upper Middle 
7 + + 
2 + + 
6 + + 
2 + + 
7 + + 
2 + + 
5 + + 
2 + + 
+ + 
" FlTC-M.H.: nuorescein la beled y-globulins from a patient with pemphigus foliaceus. 
" FITC-T.Y.: flu orescein la beled y-globu lins from a patient with pemphigus vulgaris. 
·· NHS: normal human serum at 1:10 dil ut ion for co ntrol. 
FITC-T.Y.1' 
Lower Upper Middle Lower 
± + 
± + 
± + 
± + 
± + 
± + 
± + 
/ 
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[15]. Heterogeneity of the BP antibodies has not been pointed 
out to date , though some controversial observations have been 
reported about the immunoelectron microscopic findings of 
immunoglobulin deposition of BP skin [8,9,16]. Furthermore it 
was suggested from our study that BP antibodies were produced 
so as to reflect more of epidermal component of BMZ, since the 
positive correlation of reactivity of BP antibodies with pem-
prugus antibodies were demonstrated by the blocking experi-
ment using FITC labeled pemphigus antibodies. Whether or 
not this basal cell fluorescence is related to the so-called basal 
cell cytoplasmic antibodies reported by van Joost and several 
others [1 7] remains to be solved, since basal cell antibodies a re 
demonstrab le without concomitant occurrence of antibodies to 
the BMZ. 
SeveJfal immunochemical observation revealed close a nti-
genic reiationships between BMZ antigens and the epidermal 
antigens. Diaz et al [10] extracted PBS-soluble proteins from 
human skin by the treatment with 2N NaSCN which splits the 
e pidermis at the level of the lamina Iucida leaving the BP 
antigens attached to the epidermal sheet and isolated a protein 
moiety by gel filtration and ion exchange chromatography. This 
purified protein was able to block the staining ofBMZ produced 
by BP antibodies. Interestingly, the same authors [18] found 
human saliva and mine contain substances which are reactive 
with both BP and pemphigus antibod ies as detected by reverse 
passive hemagglutinations, suggesting pemphigus and BP an-
tigens are immunologically related. Phylogenetic studies have 
also suggested that BP antigen, a more primitive antigenic 
moiety, gave rise to the pemphigus antigen dLU·ing evolution 
[19]. Earlier IF studies by De Moragas, Winkelmann, and 
Jordon [20] revealed cytoplasrruc fluorescence of basal cells in 
association with BMZ fluorescence using BP antibodies by the 
ordinary IgG indirect IF and concluded that their findings point 
to the elaboration of BMZ antigen by the basal or germinative 
cells of the epidermis. Bockendahl et al [21] suggested some 
relationships between the antigen of the BMZ and that of the 
res of epidermal cells from their careful histochemical analysis 
of the binding sites of BP anti bodies. Our present study has 
provided stronger evidence that the ant igenic property of BMZ 
as reflected by BP antibodies is more subject to the natm e of 
e pidermal cells on the BMZ. In other words, BMZ antigens 
may be of epithelial origin as described by Pierce et al [22] and 
therefore BP antibodies are able to bind with the antigens in 
t he cytoplasm, BCM and ICS or basal cells on their way to the 
secretion to BMZ, although the intensity of fluorescence de-
pends upon the amount of antigens or reactivity of BP serum. 
Precise localization of the substances should be further decided 
by the immuno-electron microscopy. 
We a re most grateful to those who kindly supplied the bullous 
pemphigoid sera used in the present study and Mrs. Yoshiko Fujii for 
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